GLP-1 Medications: Does Insurance Cover Ozempic, Wegovy, or Mounjaro?

GLP-1 Medication Insurance Coverage: What You Need to Know About Ozempic, Wegovy, and Mounjaro

If you've been researching weight loss options lately, you've almost certainly come across GLP-1 medications like Ozempic, Wegovy, and Mounjaro. These drugs have generated enormous buzz — and for good reason. Clinical evidence suggests they can produce meaningful, sustained weight loss for many people. But there's a catch that stops a lot of people in their tracks: the price tag. Without insurance, these medications can cost $900 to $1,300 or more per month. That's why understanding GLP-1 medication insurance coverage is often the very first step on the path to treatment.

This guide breaks down how insurance coverage for these medications actually works, what criteria you'll typically need to meet, and what you can do if your first request is denied.

What Are GLP-1 Medications, and Why Are They So Expensive?

GLP-1 stands for glucagon-like peptide-1, a hormone your body naturally produces to regulate blood sugar and appetite. GLP-1 receptor agonists are medications that mimic this hormone, helping people feel fuller faster and reducing overall calorie intake. The most well-known names in this category include:

• Semaglutide (Ozempic) — FDA-approved for type 2 diabetes management
• Semaglutide (Wegovy) — FDA-approved specifically for chronic weight management
• Tirzepatide (Mounjaro) — FDA-approved for type 2 diabetes; its weight-loss version, Zepbound, is approved for obesity
• Liraglutide (Saxenda) — An older GLP-1 option approved for weight management

These medications are expensive largely because they are still under patent protection and involve complex manufacturing processes. Manufacturers like Novo Nordisk and Eli Lilly set list prices that reflect both research investment and market demand. Until generic versions become available, most patients will need insurance or manufacturer assistance programs to make treatment financially feasible.

Does Insurance Cover GLP-1 Medications? The Honest Answer

The short answer is: it depends — and the details matter a lot. Coverage varies widely based on your specific insurance plan, the diagnosis your provider documents, and whether the medication is being prescribed for diabetes or for weight loss.

Here's a general breakdown of how different types of insurance tend to approach these medications:

• Employer-sponsored commercial insurance: Coverage is highly variable. Some large employers explicitly cover FDA-approved obesity medications; others exclude them entirely. It's worth calling the member services number on your insurance card and asking specifically about your formulary (the list of covered drugs).
• Medicare: Part D plans have historically excluded weight-loss medications, though this is beginning to change. Ozempic and Mounjaro may be covered when prescribed for diabetes. As of recent legislative updates, coverage for obesity medications under Medicare is an evolving area — consult your plan or a benefits counselor for the latest information.
• Medicaid (including Maryland Medicaid): Coverage varies by state. Maryland Medicaid has expanded coverage for certain obesity treatments, but prior authorization is typically required. Talk to your provider about what documentation will support your case.
• ACA Marketplace plans: Coverage depends on the specific plan tier and insurer. Some Silver and Gold plans include GLP-1 coverage for obesity; others do not.

One important nuance: the same molecule can have different coverage depending on what it's prescribed for. For example, Ozempic (semaglutide for diabetes) is more widely covered than Wegovy (semaglutide for weight loss), even though they contain the same active ingredient. Your provider's documentation of your diagnosis plays a significant role in what gets approved.

What Criteria Do You Typically Need to Meet?

Even when a plan does cover GLP-1 medications for weight management, insurers almost always require you to meet specific clinical criteria before approving coverage. These criteria are designed to ensure the medication is being used appropriately and that other interventions have been considered. Common requirements include:

• A BMI of 30 or higher (classified as obesity), or a BMI of 27 or higher with at least one weight-related health condition such as high blood pressure, type 2 diabetes, or sleep apnea
• Documentation of previous weight loss attempts, such as participation in a structured diet or exercise program
• A prescription from a licensed healthcare provider who has documented your medical history and the clinical rationale for treatment
• Prior authorization from your insurer, meaning your doctor must submit paperwork justifying the prescription before the plan will pay
• In some cases, enrollment in or referral to a medically supervised weight management program

Working with a physician who is experienced in obesity medicine or metabolic health can make a significant difference here. Proper documentation of your health history, previous efforts, and current conditions strengthens a prior authorization request considerably.

What to Do If Your Insurance Denies Coverage

A denial isn't necessarily the end of the road. Insurance companies are required to provide a reason for denial, and you have the right to appeal. Here are a few steps worth considering:

• Request a formal appeal: Your provider can submit additional clinical documentation to support the medical necessity of the medication.
• Ask about manufacturer savings programs: Novo Nordisk and Eli Lilly both offer savings cards and patient assistance programs that can significantly reduce out-of-pocket costs for eligible patients.
• Explore compounded semaglutide with caution: During periods of drug shortage, some compounding pharmacies have offered lower-cost versions. However, the FDA has raised safety concerns about compounded GLP-1 medications — always discuss this option thoroughly with your healthcare provider before considering it.
• Check if your employer plan can be updated: Open enrollment periods may be an opportunity to switch to a plan with better obesity medication coverage.

How MetroAI Can Help You Navigate Coverage in Maryland

Figuring out whether your insurance covers GLP-1 medications — and meeting all the right criteria — can feel overwhelming. MetroAI's physician-led weight loss program is designed to help Maryland residents navigate exactly this process. You can check your insurance eligibility at metroai.app/maryland-weight-loss for free, with no commitment required, to find out whether your plan may cover GLP-1 treatment through a medically supervised program.

This article is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare provider about your individual health situation.